Literature DB >> 28604279

Diffusion and Intravoxel Incoherent Motion MR Imaging-based Virtual Elastography: A Hypothesis-generating Study in the Liver.

Denis Le Bihan1, Shintaro Ichikawa1, Utaroh Motosugi1.   

Abstract

Purpose To investigate the potential of diffusion magnetic resonance (MR) imaging to provide quantitative estimates of tissue stiffness without using mechanical vibrations in patients with chronic liver diseases and to generate a new elasticity-driven intravoxel incoherent motion (IVIM) contrast. Materials and Methods This retrospective study, conducted from January to April 2016, was approved by an institutional review board that waived the requirement for informed consent. Fifteen subjects were included (13 men and two women; mean age ± standard deviation, 73 years ± 8). MR elastography and diffusion MR imaging were performed at 3 T. A search for an empirical relationship between MR elastographic shear modulus, µMRE, and a shifted apparent diffusion coefficient (sADC) was performed. The sADC was then inverted to estimate patient liver shear modulus directly from diffusion MR imaging signals. Results A significant correlation (r2 = 0.90, P = 1 · 10-7) was observed between µMRE and sADC calculated by using diffusion MR imaging signals acquired with b values of 200 (S200) and 1500 (S1500 ) sec/mm2 (sACD200-1500). On the basis of the relationship between the µMRE and sADC200-1500, a diffusion-based shear modulus, µdiff, could be estimated with the following equation: µdiff = (-9.8 ± 0.8) ln(S200/S1500) + (14.0 ± 0.9). IVIM virtual elastograms also could be generated to reveal new contrast features in lesions, depending on pseudovibration frequency and amplitude. Conclusion Diffusion MR imaging, through a calibration of sADC200-1500 with standard MR elastography, can be converted quantitatively into shear modulus without using mechanical vibrations to provide information on the degree of liver fibrosis; these virtual elastograms require only two b values to be acquired and processed. Propagating shear wave can also be emulated, leading to a new elasticity-driven IVIM contrast with ranges of virtual vibration frequencies and amplitudes not limited by MR elastography or MR imaging hardware capacities. © RSNA, 2017 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2017        PMID: 28604279     DOI: 10.1148/radiol.2017170025

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Authors:  D Marti-Aguado; A Rodríguez-Ortega; A Alberich-Bayarri; L Marti-Bonmati
Journal:  Abdom Radiol (NY)       Date:  2020-08-28

2.  Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B.

Authors:  Qingtao Li; Tianyou Chen; Nannan Shi; Wen Ye; Min Yuan; Yuxin Shi
Journal:  Abdom Radiol (NY)       Date:  2021-11-25

3.  Quantitative diffusion MRI of the abdomen and pelvis.

Authors:  Diego Hernando; Yuxin Zhang; Ali Pirasteh
Journal:  Med Phys       Date:  2021-10-08       Impact factor: 4.506

4.  Evaluation of the efficacy of transcatheter arterial embolization combined with apatinib on rabbit VX2 liver tumors by intravoxel incoherent motion diffusion-weighted MR imaging.

Authors:  Can Chen; Xiao Liu; Lingling Deng; Yunjie Liao; Sheng Liu; Pengzhi Hu; Qi Liang
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

Review 5.  Transformational Role of Medical Imaging in (Radiation) Oncology.

Authors:  Catherine Coolens; Matt N Gwilliam; Paula Alcaide-Leon; Isabella Maria de Freitas Faria; Fabio Ynoe de Moraes
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.639

Review 6.  Perfusion-driven Intravoxel Incoherent Motion (IVIM) MRI in Oncology: Applications, Challenges, and Future Trends.

Authors:  Mami Iima
Journal:  Magn Reson Med Sci       Date:  2020-06-15       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.